Toker lab identifies metabolic vulnerability in TNBC

March 2, 2017

Ludwig researchers have shown that triple-negative breast cancer cells ramp up production of a key component of DNA in response to chemotherapy and that targeting this pathway could undermine their resistance to such therapies.

Coverge from Ludwig Cancer Research here.

Cancer Discovery publication here.